Latest stories on OCGN
Ocugen: Q3 Data Catalyst In Stargardt Disease Feels Critical
Seeking Alpha63 · neutralproduct/pr
Ocugen Inc. stock falls Thursday, underperforms market
MarketWatch42 · neutralgeneral
Ocugen: My Hold Rating Continued On OCU410ST Advancement And Upcoming Catalysts
Seeking Alpha52 · neutralanalyst
H.C. Wainwright cuts Ocugen stock price target to $9.50 on trial delay
Investing.com Analyst Ratings34 · bearishanalyst
Ocugen price target lowered to $9.50 from $10 at H.C. Wainwright
The Fly42 · neutralanalyst
Ocugen Inc. stock falls Wednesday, underperforms market
MarketWatch42 · neutralgeneral
Ocugen slips after interim trial data for Stargardt disease candidate
Seeking Alpha32 · bearishproduct/pr
Ocugen Inc. stock falls Tuesday, underperforms market
MarketWatch42 · neutralgeneral
Ocugen, Inc. (OCGN) files 8-K
SEC 8-K50 · neutralgeneral
Ocugen doses first patient in OCU410 trial
The Fly56 · neutralproduct/pr
Ocugen to Participate in Upcoming September Investor and Industry Conferences
GlobeNewswire56 · neutralgeneral
Ocugen to Participate in Upcoming September Investor and Industry Conferences
StockTitan56 · neutralgeneral
Ocugen Inc. stock falls Thursday, underperforms market
MarketWatch42 · neutralgeneral
Ocugen Inc. stock rises Wednesday, outperforms market
MarketWatch58 · neutralgeneral
Ocugen Inc. stock falls Tuesday, underperforms market
MarketWatch42 · neutralgeneral
Ocugen Inc. stock falls Thursday, underperforms market
MarketWatch42 · neutralgeneral
Ocugen (OCGN) Q2 2026 Earnings Call Transcript
Yahoo Top63 · neutralearnings
Ocugen (OCGN) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Ocugen Inc. stock rises Wednesday, outperforms market
MarketWatch58 · neutralgeneral
Ocugen Inc. stock rises Tuesday, outperforms market
MarketWatch58 · neutralgeneral
Ocugen Q2 Earnings Call Highlights
Yahoo Top67 · bullishearnings
Ocugen, Inc. (OCGN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Ocugen, Inc. (OCGN) files 8-K
SEC 8-K50 · neutralgeneral